Literature DB >> 7462626

A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.

C L Geczy, K E Hopper.   

Abstract

Although lymphokine supernatants had no procoagulant activity per se, guinea pig peritoneal exudate cells (PEC), incubated with lymphokine supernatants or with a lymphokine fraction of 35,000 to 50,000 daltons decreased the recalcification time of platelet-poor plasma. PEC from animals immunized with BCG or with ovalbumin and incubated with the corresponding antigen had increased procoagulant activity. Similar effects were observed with PEC incubated with endotoxin. The induction of procoagulant activity by the cells was accompanied by a concomitant decrease in their ability to respond to chemotactic agents and to migrate from capillary tubes. Separation of exudate cells by sedimentation velocity indicated that large macrophages had the highest degree of procoagulant activity after incubation with lymphokines. The clotting time of Factor IX-deficient plasma was decreased by lymphokine-treated macrophages, indicating that the extrinsic clotting sequence may be activated as a result of increased tissue factor on the treated cells. Heparin abolished the ability of lymphokines to inhibit macrophage migration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462626

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Macrophage procoagulant activity as an assay of cellular hypersensitivity to gluten peptides in coeliac disease.

Authors:  J M Devery; C L Geczy; D DeClarle; J H Skerritt; S A Krillis
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

Authors:  S T Smiley; S N Boyer; M J Heeb; J H Griffin; M J Grusby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Induction of procoagulant activity in human epidermal cells.

Authors:  A Schöne; E Zimmermann; J Knop
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Glomerular procoagulant activity in human proliferative glomerulonephritis.

Authors:  P G Tipping; J P Dowling; S R Holdsworth
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

5.  Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits.

Authors:  P G Tipping; M G Lowe; S R Holdsworth
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

Review 6.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

7.  Expression of macrophage procoagulant activity in murine systemic lupus erythematosus.

Authors:  E H Cole; J Sweet; G A Levy
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Tissue factor activity. A marker of alveolar macrophage maturation in rabbits. Effects of granulomatous pneumonitis.

Authors:  H Rothberger; M P McGee; T K Lee
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

Authors:  A W Thomson; D K Moon; Y Inoue; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

10.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.